Eptifibatide CAS:188627-80-7

Short Description:

Eptifibatide is used to inhibit platelet aggregation for the treatment of acute coronary syndrome and the prevention of cardiac thrombosis.


Product Detail

Product Tags

Product Detail

Name: Eptifibatide  

Feature: 

Integrin is a new type of peptide platelet glycoprotein b/a receptor antagonist, which inhibits platelet aggregation and thrombosis through the last common way of inhibiting platelet aggregation.

Compared with the monoclonal antibody abciximab, etibalide has stronger binding to GP b/a, more directivity and specificity due to the existence of a single conservative amino acid substitution-lysine instead of arginine.

Therefore, it should play a good role in the interventional treatment of acute coronary syndrome.

 

Composition:

Assay: 99%

Appearance: White powder

CAS No. 188627-80-7

Packing: 25kg

Shelf Life: 2 years

Storage: Store in cool and dry area

Certification:ISO.


  • Previous:
  • Next:

  • Related Products